Teachers Advisors’s aTyr Pharma ATYR Stock Holding History

Teachers Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-632	Closed	-$35K	–	3168
2016 Q1	$35K	Hold	632	–	–	﹤0.01%	3016
2015 Q4	$87K	Hold	632	–	–	﹤0.01%	3031
2015 Q3	$91K	Hold	632	–	–	﹤0.01%	3017
2015 Q2	$164K	Buy	+632	New	+$196K	﹤0.01%	3013

Other funds holding ATYR

RCM

Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Teachers Advisors's ATYR Position: Q2 2016 in Review

Teachers Advisors sold out of aTyr Pharma (ATYR) in Q2 2016, closing a stake of 632 shares — an estimated $35K sold.

Teachers Advisors first reported a position in ATYR in Q2 2015 and held it in 4 quarters. The position peaked at $164K in Q2 2015. 49 funds tracked by Wall St. Rank hold ATYR as of Q2 2016.

Teachers Advisors reported no remaining aTyr Pharma position as of Q2 2016 after selling out during the quarter.
Teachers Advisors sold 632 aTyr Pharma shares in Q2 2016, an estimated $35K.
Teachers Advisors first reported a position in aTyr Pharma in Q2 2015 and held it in 4 quarters.
Teachers Advisors's aTyr Pharma position peaked at $164K in Q2 2015.
49 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2016.

Based on Teachers Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.